Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 2020

View Archived Issues

MMA induces epithelial-to-mesenchymal transition

CAR T cells for inhibition

First healthy volunteers enrolled in phase I study of GRAd-COV2 COVID-19 vaccine candidate

Trevena initiates proof-of-concept study of TRV-027 in patients with COVID-19

BIIB-091: a potent, highly selective BTK inhibitor for the treatment of multiple sclerosis

GB-1211, first orally available galectin-3 inhibitor as potential treatment for NASH

Nicotinamide riboside suppresses inflammatory activation of PBMC in heart failure

Kyorin Pharmaceutical presents new 15-PGDH inhibitors

New DNA polymerase theta inhibitors discovered at Ideaya Biosciences

Foghorn Therapeutics patents PROTACs targeting BRD9

Canwell Biotech identifies new TLR7/8 agonists

New sphingomyelin phosphodiesterase 3 inhibitors discovered at Johns Hopkins University

Antifungal immunity helps out antibacterial vaccine

FDA clears IND for phase II study of RGX-314 for diabetic retinopathy

Immunogenicity of an saRNA lipid NP vaccine candidate encoding the SARS-CoV-2 S protein in mice

Topline data presented from phase II ELEKTRA study of soticlestat

AtlasMedx initiates phase I/II study of AMXI-5001 in advanced malignancies

Positive topline data from phase IIa trial of IMVT-1401 in myasthenia gravis

Mereo BioPharma initiates phase Ib/II study of alvelestat in COVID-19 respiratory disease

Phase III ASCEMBL study of asciminib in CML meets primary endpoint

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...